{"changes":[],"country":"FR","description":"Peptinov develops peptide-based active immunotherapies that train patients to produce antibodies against their own pathogenic targets. It serves patients with chronic inflammatory diseases and the pharma partners that license its platform assets. The peptide-based active vaccination approach is positioned as a cheaper, longer-acting alternative to monoclonal antibody therapy.","domain":"peptinov.fr","employees":null,"founded":null,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"biotech","investors":[],"lat":46.6034,"lng":1.8883,"location":"France","name":"Peptinov","rounds":[{"amountQuarantined":false,"amountUsd":2700000,"currency":"EUR","date":"2023-07-01","investors":[],"leadInvestor":null,"source":{"fact":"round","publisher":"eu-grant","retrievedAt":"2026-05-07","status":"attributed","url":null},"status":"attributed","type":"grant","url":null}],"slug":"peptinov-fr","sources":[{"fact":"round","publisher":"eu-grant","retrievedAt":"2026-05-07","status":"attributed","url":null},{"fact":"existence","publisher":"peptinov.fr","retrievedAt":"2026-05-07","status":"self-reported","url":"https://peptinov.fr"},{"fact":"description","publisher":"peptinov.fr","retrievedAt":"2026-05-07","status":"self-reported","url":"https://peptinov.fr"}],"stage":null,"techStack":["Vue.js 2.6.14","vue 2.6.14"],"totalRaisedUsd":2700000,"updatedAt":"2026-05-07"}